Skip to main content

Table 1 Comparison of socio-demographic characteristics and baseline parameters of patients in overall sample, study and control groups (p < 0.05)a

From: A quick relaxation exercise for people with chronic obstructive pulmonary disease: explorative randomized controlled trial

Variables

Experimental group

(n = 19)

Control group

(n = 19)

Socio- demographic data

Sex (n, %)

 Female

8 (42.10)

7 (36.80)

 Male

11 (57.90)

12 (63.20)

Age (years) (Mean, SD)

72.53 (10.30)

72.79 (7.06)

Weight (Mean, SD)

72.32 (16.63)

69.59 (13.24)

Height (Mean, SD)

164.32 (8480)

165.26 (10.13)

BMIb (Mean, SD)

26.88 (6.46)

25.5 (4.85)

Educational level (n, %)

 None

1 (5.30)

0 (0)

 Primary School

7 (36.80)

9 (47.40)

 Junior High School

7 (36.80)

6 (31.60)

 High School

4 (21.10)

3 (15.80)

 Graduated or higher education

0 (0)

1 (5.30)

Profession/Job done longer in the past (n, %)

 Housewife

4 (21.10)

2 (10.50)

 Employee

5 (26.30)

2 (10.50)

 Laborer

4 (21.05)

8 (42.10)

 Professional

5 (26.30)

5 (26.30)

 Manager

1 (5.30)

2 (10.50)

Medical and clinical data

Duration of Illness (Mean, SD)

1.79 (0.78)

2.26 (0.80)

 5 (n, %)

8 (42.10)

4 (21.10)

 10 (n, %)

7 (36.80)

6 (31.60)

  > 15 (n, %)

4 (21.10)

9 (47.40)

Smoking (n, %)

 Never

2 (10.50)

0 (0)

 Yes

6 (31.10)

7 (36.80)

 Quitted

11 (57.90)

12 (63.20)

Drugs (n, %)

 LAMA Ib

15 (78.90)

17 (89.50)

 LABA Ib

17 (89.5)

18 (94.70)

 ICSb

12 (63.20)

10 (52.60)

 Anxiolytics

3 (15.80)

9 (47.40)

 Antidepressants

3 (15.80)

4 (21.10)

Exacerbation, last year (n, %)

  < 1

12 (63.20)

10 (52.60)

 1–3

6 (31.60)

9 (47.40)

  > 3

1 (5.30)

0 (0)

Hospitalization, last year (n, %)

  < 1

13 (68.40)

11 (57.90)

 2

5 (26.30)

8 (42.10)

  > 2

1 (5.30)

0 (0)

mMRCc

2.47 (0.51)

2.21 (0.41)

CATc

28.79

30.68

  1. aData are presented as Mean+/-Standard Deviation (SD) and number, percentage (n, %)
  2. bBMI Body Mass Index, LAMA Long-Acting Muscarinic Antagonists, LABA Long-Acting Beta 2-Adrenergic Agonists, ICS Inhaled Corticosteroids
  3. cmMRC Modified Medical Research Council Dyspnoea Scale, CAT COPD Assessment Test